扩张型心肌病继发顽固性心力衰竭采取米力农短期小剂量干预的临床研究

目的：研究扩张型心肌病继发顽固性心力衰竭采取米力农短期小剂量干预的临床效果。方法整群选取该院2013年11月—2015年11月收治的104例扩张型心肌病继发顽固性心力衰竭患者参照随机数字表法将其分为各52例的对照组与研究组，在两组常规贯彻抗心衰治疗前提下研究组还辅以短期小剂量米力农治疗。从疗效、心功能改善、不良反应进行综合评估。结果研究组的临床总好转率为94.2%，显著优于对照组的76.9%；研究组治疗后各心功能指标改善显著优于对照组；两组不良反应发生率差异无统计学意义。结论扩张型心肌病继发顽固性心力衰竭采取米力农短期小剂量干预疗效确切，心功能改善明显，安全性好。

Clinical Study of Dilated Cardiomyopathy Secondary to Intractable Heart Failure to Take Low-Dose Milrinone Short-Term Intervention

Objective Study of dilated cardiomyopathy secondary to intractable heart failure to take the clinical effect of milrinone short-term low-dose intervention. Methods Group collected in our hospital from November 2013 to November 2015 treated 104 cases of dilated cardiomyopathy secondary to intractable heart failure patients according to random num-ber table method, which is divided into 52 cases in the control group and the study group, in both groups were routinely carry out anti heart failure treatment under the premise of the research group is complemented by short-term low-dose Mil-rinone Treatment. Comprehensive evaluation of efficacy, improvement of cardiac function and adverse reactions. Results The clinical total improvement rate of the study group was 94.2%, significantly better than 76.9% of the control group; the im-provement of the cardiac function after treatment was significantly better than the control group;the incidence of adverse re-actions in the two groups had no significant difference. Conclusion The dilated cardiomyopathy secondary to intractable heart failure take milrinone low dose of intervention in short-term curative effect, significant improvement in cardiac func-tion and safety.